Cargando…

COVID-19 Booster Vaccine Equity for Patients With Cancer

COVID-19 has caused greater than 300 million documented infections worldwide including over 5 million confirmed deaths. Patients with cancer are particularly vulnerable due to a combination of disease and therapy-related effects. Available vaccines were highly effective against the original viral st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prasad, Rahul N., Patel, Manali, Palmer, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Brief Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904322/ https://www.ncbi.nlm.nih.gov/pubmed/35280348 http://dx.doi.org/10.1016/j.adro.2022.100939

Ejemplares similares

Financial Toxicity as an End Point in Prospective Clinical Trials Involving Radiation Therapy
por: Prasad, Rahul N., et al.
Publicado: (2022)

COVID-19 vaccine equity and booster doses
por: The Lancet Infectious Diseases
Publicado: (2021)

COVID-19 booster doses in pregnancy and global vaccine equity
por: Kalafat, Erkan, et al.
Publicado: (2022)

Gender Equity in Radiation Oncology: Culture Change Is a Marathon, Not a Sprint
por: Schuster, Jessica M., et al.
Publicado: (2022)

Challenges and Solutions for Establishing Robust Diversity, Equity, and Inclusion Efforts in US Academic Radiation Oncology Departments
por: Beltrán Ponce, Sara, et al.
Publicado: (2023)

COVID-19 Booster Vaccination Bellwethers: Factors Predictive of Older Adults’ Adoption of the Second Booster COVID-19 Vaccine in Israel: A Longitudinal Study
por: Ben-David, Boaz M., et al.
Publicado: (2023)

Private Equity–Backed Hospital Investments and the Impact of the Coronavirus Disease 2019 (COVID-19) Epidemic
por: Lexa, Frank J., et al.
Publicado: (2020)

Efficacy of COVID-19 vaccine booster doses in older people
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Financial Toxicity: A Barrier to Achieving Health Equity in Cancer Care
por: Tucker-Seeley, Reginald D.
Publicado: (2023)

Gender Equity in Academic Medicine
por: Sandhu, Nimrat Kaur, et al.
Publicado: (2023)

COVID-19 Booster Vaccination in the U.S. Military, August 2021–January 2022
por: Winkler, Erin L., et al.
Publicado: (2023)

Designing the Crops for the Future; The CropBooster Program
por: Harbinson, Jeremy, et al.
Publicado: (2021)

Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
por: Park, Seon Kyeong, et al.
Publicado: (2023)

COVID-19 Booster Vaccine Hesitancy in the Emergency Department
por: Molina, Melanie F., et al.
Publicado: (2023)

Chicago’s Citywide COVID-19 Vaccine Equity Program: Protect Chicago Plus
por: Johnson, Amy K., et al.
Publicado: (2023)

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
por: Wroński, Jakub, et al.
Publicado: (2023)

Centering health equity in large language model deployment
por: Singh, Nina, et al.
Publicado: (2023)

Interactive, on-line visualization tools to measure and drive equity in COVID-19 vaccine administrations
por: Shaheen, Amy W, et al.
Publicado: (2021)

Ensuring health equity during the COVID-19 pandemic: the role of public health infrastructure
por: Benjamin, Georges C.
Publicado: (2020)

COVID-19 Vaccine Booster: To Boost or Not to Boost
por: Shekhar, Rahul, et al.
Publicado: (2021)

Serological response to a third booster dose of BNT162b2 COVID‐19 vaccine among seronegative cancer patients
por: Shmueli, Einat Shacham, et al.
Publicado: (2022)

Discussion of the Trust in Vaccination against COVID-19
por: Fan, Jiangbo, et al.
Publicado: (2022)

Complement Factors in COVID-19 Therapeutics and Vaccines
por: Kurtovic, Liriye, et al.
Publicado: (2021)

COVID-19 Vaccination and the Challenge of Infodemic and Disinformation
por: Farooq, Fareeha, et al.
Publicado: (2021)

Patient-Guided Talking Points to Address COVID-19 and General Vaccine Hesitancy
por: Nguyen, Elaine, et al.
Publicado: (2022)

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?
por: Lundstrom, Kenneth, et al.
Publicado: (2021)

COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic
por: Sharun, Khan, et al.
Publicado: (2021)

Paris Agreement on Climate Change: A Booster to Enable Sustainable Global Development and Beyond
por: Bhore, Subhash Janardhan
Publicado: (2016)

Equity in global health research: A proposal to adopt author reflexivity statements
por: Saleh, Sepeedeh, et al.
Publicado: (2022)

How to prevent equity efforts from losing steam in global health academia
por: Bandara, Shashika, et al.
Publicado: (2023)

The COVID-19 vaccination campaign in Bhutan: strategy and enablers
por: Tsheten, Tsheten, et al.
Publicado: (2022)

Vaccinating the world against COVID-19 is a no-brainer
por: Stiglitz, Joseph E.
Publicado: (2022)

Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy
por: Desai, Saral, et al.
Publicado: (2023)

Prevalence and Motivators of Getting a COVID-19 Booster Vaccine in Canada: Results from the iCARE Study
por: Léger, Camille, et al.
Publicado: (2023)

COVID-19 booster vaccination coverage among adults, children and adolescents and reasons for non-receipt, United States
por: Nguyen, Kimberly H., et al.
Publicado: (2023)

Benefits and potential harms of COVID‐19 vaccination during pregnancy: evidence summary for patient counseling
por: Kalafat, E., et al.
Publicado: (2021)

Access to COVID-19 Vaccines: A New Global Approach
por: Bouderhem, Rabaï
Publicado: (2022)

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
por: Calcaterra, Giuseppe, et al.
Publicado: (2021)

The global COVID-19 vaccine surplus: tackling expiring stockpiles
por: Quan, Nguyen Khoi, et al.
Publicado: (2023)

The Effects of the COVID-19 Pandemic on Vaccination Hesitancy: A Viewpoint
por: Leonardelli, Mirko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7auv3rv2h4328q2ovo2l4m7bc6